Vivacelle Bio had a very successful clinical trial of our phospholipid nanoparticles in patients who had severe septic shock. he study was published in the Lancet's eClinicalmedicine. The company is moving on to phase III. https://lnkd.in/ejD7aFtW
Vivacelle Bio, Inc.’s Post
More Relevant Posts
-
🔬New research: In a phase 1 maximal-use trial exploring the plasma pharmacokinetics, safety, and tolerability of #tirbanibulin on a 100 cm2 field, researchers presented data supporting its potential use in larger affected areas. https://lnkd.in/g5Ze3eWH
Phase 1 Maximal Use Trial of Tirbanibulin Ointment 1% in Actinic Keratosis Exhibits Favorable Safety and Tolerability
dermatologytimes.com
To view or add a comment, sign in
-
We are pleased to announce that we have completed recruitment in our Phase II clinical trial of LEVI-04, a novel neurotrophin-modulating biological agent. Our founder and CSO, and study director Simon Westbrook noted, “The fact we completed recruitment in this large-scale Phase II in under a year is testament to physicians’ interest in our programme and patients’ pressing need for new treatment options for their chronic pain.” A once-a-month injectable for the treatment of osteoarthritis and chronic pain, LEVI-04 is a proprietary p75 neurotrophin receptor fusion protein (p75NTR-Fc) designed to deliver neurotrophin homeostasis. The multiple arm, multicentre, prospective, randomized, double-blind, placebo-controlled, Phase II study has enrolled more than 500 participants with pain due to osteoarthritis of the knee (ClinicalTrials.gov ID: NCT05618782). Top line data are expected to be announced in late first half of 2024. Read the news HERE https://lnkd.in/e4H-vQT3 #biotech #drugdevelopment #chronicpain #osteoarthritis #clinicaltrial
To view or add a comment, sign in
-
😊 Collagen Daily-Benefits of Collagen peptides for the liver According to a clinical study report(patients were randomly investigated), Patients took collagen peptide, 90 out of 100 cases, albumin increased, the effective rate was 90%; In 100 cases, 92 cases of globulin decreased, the effective rate was 92%, the curative effect was very significant. 😍 A lot of practice and clinical proof, small molecule collagen peptide it can boost albumin, restore liver function, and can reverse cirrhosis and liver ascites. 😘 Hainan Huayan focus on small molecule collagen peptide over 19 years, welcome to contact us when you want to know more . #collagenpeptide #collagensupplement #collagenbenefits
To view or add a comment, sign in
-
Source: The Analyst A high-throughput paper spray mass spectrometry (PS-MS) method is presented for simultaneous quantitation of urinary albumin and creatinine for diagnosing albuminuria. The method requires minimal or no sample preparation and showed good analytical performance. It was applied to determine albumin-to-creatinine ratios in human patient urine samples, achieving a strong correlation with validated clinical method results. PS-MS has potential as a tool for clinical albuminuria diagnostics.
Simultaneous quantitation of urinary albumin and creatinine for rapid clinical albuminuria diagnostics using high-throughput paper spray mass spectrometry
pubmed.ncbi.nlm.nih.gov
To view or add a comment, sign in
-
#ACROHighlights [Featured Product] 🚀 Harnessing Cardiac Organoids for Enhanced Drug Development 🌟 Drug-induced cardiotoxicity is a significant challenge in new drug development. Due to their physiological relevance and reproducibility, cardiac organoids derived from iPSCs are now a game-changer for high-throughput drug safety screening. At ACROBiosystems, we've developed cardiac organoids that accurately predict drug-induced cardiotoxicity. But we don't stop there! Our ongoing research also covers other organoid models, including brain, liver, and intestines, to offer comprehensive support for future clinical trials. Join us at the forefront of innovation in drug development! 💊✨ 🔗https://lnkd.in/gzPuS_xg #Biotech #DrugDevelopment #CardiacOrganoids #iPSCs #ClinicalTrials
To view or add a comment, sign in
-
💉 The Cleveland-based company designed Injectrode to treat chronic pain. The LIFE trial evaluated Injectrode’s safety and effectiveness, meeting all goals, Neuronoff, Inc. said. “The study comprised a major leap forward for the development of the Injectrode, providing valuable information that builds upon the company’s prior preclinical testing, including assessment of tolerability of sensory perception during stimulation, and first-in-human feasibility of the Injectrode’s transcutaneous stimulation approach,” Neuronoff Chief Scientific Officer Andrew Shoffstall said. 🔗 Learn more: https://lnkd.in/d7YpfqPj 📰 Follow Guided Solutions to receive the latest #MedTech news daily and subscribe to our weekly newsletter: https://lnkd.in/dht_9YcQ #MedicalDevices #MedicalDevice #MedicalEquipment #Medicine #Surgeons #GuidedSolutions
Neuronoff hits first-in-human milestone for Injectrode neuromod
https://news.gsmedtech.com
To view or add a comment, sign in
-
Endeavor BioMedicines’ ENV-101 is a hedgehog pathway inhibitor for adults with idiopathic pulmonary fibrosis (#IPF). Investigator Toby Maher, M.D., Ph.D. from the Keck School of Medicine of the University of Southern California recently discussed new data from the ENV-101 Phase 2a clinical trial with Isabella Hornick at Healio. "The placebo group acted as a placebo group should in this type of trial, which is to say that they lost lung function over the course of the 12 weeks.” Dr. Maher also commented, “What was exciting is that the treatment arm demonstrated a continuous and statistically significant improvement in lung function. This really distinguishes the data generated in this trial vs. what we’ve seen with other studies in the past, where we might only see a slowing of disease progression." Learn more about ENV-101 and what's next for the Phase 2b clinical trial: https://lnkd.in/eB6ZeqV2 #biotech #clinicaltrial
Hedgehog pathway inhibitor safe, improves lung function in IPF
healio.com
To view or add a comment, sign in
-
We summarized the clinical evidence for the Value of Platelets Rich Plasma Injections. https://lnkd.in/grmwgY8T
Clinical Evidence for Platelet-Rich Plasma PRP Injections - Modus
https://modus.org
To view or add a comment, sign in
-
It is online! This study focuses on an important aspect of personalized medicine examining the impact of individual variables such as concurrent use of other medications on clinical outcomes. Specifically, we report on the effect of gastroprotective drugs on treatment response and tolerability in women participating in the PARSIFAL study. Key messages include the importance of paying attention to concurrent therapies through a comprehensive medical history, better understanding of hematological toxicity as a surrogate for treatment exposure/activity, and continuing to explore this topic with new tablet formulations. https://lnkd.in/dNZ64EVy
Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer
sciencedirect.com
To view or add a comment, sign in
-
The 12-month FROzEN-AF US IDE clinical trial results evaluate the safety and effectiveness of the POLARx™ Cryoablation System for the treatment of symptomatic, drug refractory, recurrent, paroxysmal #atrialfibrillation (PAF). Discover the data here: https://lnkd.in/drDWJgkP #BSCEMEA #EP #Electrophysiology #ClinicalData
To view or add a comment, sign in
349 followers